Clinical Research
at UNM Comprehensive Cancer Center
The CRO at UNM Cancer Center
The CRO reviews trials initiated by:
- The National Cancer Institute
- Pharmaceutical companies
- National Clinical Trial Working groups
- UNM Cancer Center investigators
The Protocol Review and Monitoring System (PRMS) uses a two-stage process to vet the clinical trials portfolio and engage the community to assess clinical trial needs. Teresa Rutledge, MD, leads the PRMS Committee.
The CRO is also working with the newly-created Translational Science core to build a program that brings UNM Cancer Center discoveries to clinical trials.
Sarah Adams, MD, is developing the new Translational Science shared resource.
The CRO works with each of the Clinical Working Groups (CWGs) to identify and prioritize clinical trials that will benefit New Mexicans most.
- Breast CWG: U. Brown-Glaberman, MD
- GI/HPB CWG: Y. Patt, MD
- Heme CWG: L. Andritsos, MD
- Head and Neck CWG: A. Cowan, MD, PhD
- Gynecologic CWG: C. Muller, MD, FACOG
- Lung CWG: A. Kumar, MD
- Genitourinary CWG: N. Hashemi, MD
- Pediatric and AYA CWG: J. Kuttesch, PhD, MD
- Population Science CWG: A. Sussman, PhD, MCRP
The CRO is funded in part by the UNM Cancer Center’s Minority-Based National Community Oncology Program (NCORP) Grant.